The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 2009
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Administration, Oral (MeSH)
- Adrenergic beta-Antagonists (MeSH)
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- Aspirin (MeSH)
- Atenolol (MeSH)
- Capsules (MeSH)
- Cardiovascular Agents (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Diuretics (MeSH)
- Double-Blind Method (MeSH)
- Drug Combinations (MeSH)
- Drug Costs (MeSH)
- Humans (MeSH)
- Hydrochlorothiazide (MeSH)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
- India (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Primary Prevention (MeSH)
- Ramipril (MeSH)
- Research Design (MeSH)
- Secondary Prevention (MeSH)
- Simvastatin (MeSH)
- Treatment Outcome (MeSH)
published in
- Nature Reviews Cardiology Journal